Abstract:This study engineered β-carotene ketolase CrtW and β-carotene hydroxylase CrtZ to improve biosynthesis of astaxanthin in Escherichia coli. Firstly, crtW was randomly mutated to increase CrtW activities on conversion from β-carotene to astaxanthin. A crtW* mutant with A6T, T105A and L239M mutations has improved 5.35-fold astaxanthin production compared with the wild-type control. Secondly, the expression levels of crtW* and crtZ on chromosomal were balanced by simultaneous modulation RBS regions of their genes using RBS library. The strain RBS54 selected from RBS library, directed the pathway exclusively towards the desired product astaxanthin as predominant carotenoid (99%). Lastly, the number of chromosomal copies of the balanced crtW-crtZ cassette from RBS54 was increased using a Cre-loxP based technique, and a strain with 30 copies of the crtW*-crtZ cassette was selected. This final strain DL-A008 had a 9.8-fold increase of astaxanthin production compared with the wild-type control. Fed-batch fermentation showed that DL-A008 produced astaxanthin as predominant carotenoid (99%) with a specific titer of 0.88 g·L−1 without addition of inducer. In conclusion, through constructing crtW mutation, balancing the expression levels between crtW* and crtZ, and increasing the copy number of the balanced crtW*-crtZ cassette, the activities of β-carotene ketolase and β-carotene hydroxylase were improved for conversion of β-carotene to astaxanthin with higher efficiency. The series of conventional and novel metabolic engineering strategies were designed and applied to construct the astaxanthin hetero-producer strain of E. coli, possibly offering a general approach for the construction of stable hetero-producer strains for other natural products.

Efficient Biotransformation of Astragaloside IV to Cycloastragenol by Bacillus Sp. LG-502

Smith Degradation, an Efficient Method for the Preparation of Cycloastragenol from Astragaloside IV.

Highly Efficient Biotransformation of Astragaloside IV to Cycloastragenol by Sugar-Stimulated Β-Glucosidase and Β-Xylosidase from Dictyoglomus Thermophilum.

Efficient production of the anti-aging drug Cycloastragenol: insight from two Glycosidases by enzyme mining

Microbial Transformation of Astragalosides to Astragaloside IV by Absidia Corymbifera AS2

The Biotransformation of Astragalosides by A Novel Acetyl Esterase from Absidia Corymbifera As2

Microbial transformation of the anti-aging agent cycloastragenol by Mucor racemosus

Biocatalysis of Cycloastragenol by Syncephalastrum Racemosum and Alternaria Alternata to Discover Anti‐Aging Derivatives

Gastrodin Production from p -2-Hydroxybenzyl Alcohol Through Biotransformation by Cultured Cells of Aspergillus foetidus and Penicillium cyclopium

Alleviation of metabolic bottleneck by combinatorial engineering enhanced astaxanthin synthesis in Saccharomyces cerevisiae.

Biocatalysis of Cycloastragenol by Filamentous Fungi to Produce Unexpected Triterpenes

Engineering Aspergillus Oryzae A-4 Through the Chromosomal Insertion of Foreign Cellulase Expression Cassette to Improve Conversion of Cellulosic Biomass into Lipids

Promising Strategy for Improving Calycosin-7-o-β-d-glucoside Production in Astragalus Membranaceus Adventitious Root Cultures

Pharmacokinetic evidence on the contribution of intestinal bacterial conversion to beneficial effects of astragaloside IV, a marker compound of astragali radix, in traditional oral use of the herb

A solid preparation of phytochemicals: improvement of the solubility and bioavailability of astragaloside IV based on β-cyclodextrin microencapsulation

Biotransformation and bioaccessibility of active ingredients from Radix Astragali by Poria cocos during solid-state fermentation and in vitro digestion and antioxidant activity evaluation

Production of gastrodin through biotransformation of p-2-hydroxybenzyl alcohol by cultured cells of Armillaria luteo-virens Sacc

Characterization and protein engineering of glycosyltransferases for the biosynthesis of diverse hepatoprotective cycloartane‐type saponins in Astragalus membranaceus

Using UPLC-LTQ-Orbitrap-MS and HPLC-CAD to Identify Impurities in Cycloastragenol, Which Is a Pre-Clinical Candidate for COPD

Enhanced Production of Two Bioactive Isoflavone Aglycones in Astragalus Membranaceus Hairy Root Cultures by Combining Deglycosylation and Elicitation of Immobilized Edible Aspergillus Niger.

Engineering CrtW and CrtZ for improving biosynthesis of astaxanthin in Escherichia coli